Overview
Interacts with tubulin and microtubule-associated protein tau, reduces hyperphosphorylation, and promotes neurite outgrowth.
Proposed mechanism
NAPVSIPQ is the core active motif of ADNP (activity-dependent neuroprotective protein), which binds to microtubules and interacts with tau to maintain cytoskeletal integrity.
What the evidence supports
Evidence rests primarily on self-reported experience. Controlled studies are lacking.
Graded Anecdotal
Case reports, clinician notes, and user-reported outcomes. Recorded for completeness and labelled plainly so it is never mistaken for data.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
ADNP fragment neuroprotection
· DOI:10.1073/pnas.0905515106 · 2009
- [2]
NAP peptide tau interaction
· DOI:10.1016/j.jmb.2011.03.064 · 2011
- [3]
ADNP fragment neuroprotection (2009)
· · 0
- [4]
NAP peptide tau interaction (2011)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.